Bioleaders Corporation (142760) — Working Capital to Net Assets Ratio
Bioleaders Corporation (142760) has a Working Capital to Net Assets ratio of 49.3% as of December 2025. Working capital of ₩15.06 Billion (current assets of ₩26.52 Billion minus current liabilities of ₩11.46 Billion) is measured against net assets of ₩30.57 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Bioleaders Corporation (142760) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Bioleaders Corporation Working Capital to Net Assets (2015–2025)
This chart shows how Bioleaders Corporation's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 49.3%, reflecting working capital of ₩15.06 Billion against net assets of ₩30.57 Billion KRW. Check tangible equity quality of Bioleaders Corporation to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Bioleaders Corporation (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Bioleaders Corporation from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Bioleaders Corporation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.3% | ₩15.06 Billion | ₩30.57 Billion | ₩26.52 Billion | ₩11.46 Billion | ▼ -19.7 pp |
| 2024 | 69.0% | ₩25.74 Billion | ₩37.31 Billion | ₩46.37 Billion | ₩20.63 Billion | ▲ +20.6 pp |
| 2023 | 48.4% | ₩17.31 Billion | ₩35.79 Billion | ₩29.84 Billion | ₩12.53 Billion | ▲ +17.0 pp |
| 2022 | 31.4% | ₩6.80 Billion | ₩21.69 Billion | ₩71.77 Billion | ₩64.97 Billion | ▼ -80.4 pp |
| 2021 | 111.8% | ₩50.44 Billion | ₩45.11 Billion | ₩97.14 Billion | ₩46.70 Billion | ▲ +78.3 pp |
| 2020 | 33.5% | ₩10.26 Billion | ₩30.60 Billion | ₩73.53 Billion | ₩63.26 Billion | ▲ +17.9 pp |
| 2019 | 15.7% | ₩3.73 Billion | ₩23.82 Billion | ₩66.55 Billion | ₩62.82 Billion | ▲ +52.0 pp |
| 2018 | -36.3% | ₩-8.54 Billion | ₩23.50 Billion | ₩69.23 Billion | ₩77.77 Billion | ▼ -118.7 pp |
| 2017 | 82.4% | ₩28.96 Billion | ₩35.17 Billion | ₩30.91 Billion | ₩1.94 Billion | ▼ -0.5 pp |
| 2016 | 82.9% | ₩14.47 Billion | ₩17.46 Billion | ₩17.67 Billion | ₩3.20 Billion | ▲ +2.8 pp |
| 2015 | 80.1% | ₩4.45 Billion | ₩5.55 Billion | ₩7.90 Billion | ₩3.45 Billion | — |